Journal of Diabetes and Its Complications
Volume 24, Issue 3 , Pages 209-213, May 2010

Sitagliptin treatment of patients with type 2 diabetes does not affect CD4+ T-cell activation☆

  • Perrin C. White

      Affiliations

    • Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX 75390-9063, USA
    • Corresponding Author InformationCorresponding author. UT Southwestern Medical Center, Dallas, TX 75390-9063, USA. Tel.: +1 214 648 3501; fax: +1 214 648 9772.
    • PCW is the Audry Newman Rapoport Distinguished Chair in Pediatric Endocrinology.
    • ,
  • Heidi Chamberlain-Shea

      Affiliations

    • Endocrine Associates of Dallas, Dallas, TX 75093, USA
    • ,
  • Maria-Teresa de la Morena

      Affiliations

    • Department of Pediatrics, UT Southwestern Medical Center, Dallas, TX 75390-9063, USA

Received 21 May 2009; received in revised form 10 August 2009; accepted 10 September 2009. published online 26 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Disclosure statement: The authors have nothing to disclose.

PII: S1056-8727(09)00092-0

doi:10.1016/j.jdiacomp.2009.09.001

Journal of Diabetes and Its Complications
Volume 24, Issue 3 , Pages 209-213, May 2010

Article Tools

* Image Usage & Resolution